GLAUCOMA

This study is testing a small attachment called the Nanodropper that fits on standard glaucoma eye drop bottles. The goal is to see if it helps patients who have trouble aiming drops due to poor vision or hand issues use their medication more accurately and consistently. Research…

This study is testing whether a short, structured education program can help glaucoma patients in Nepal stick to their prescribed treatments. About 60 adult patients with glaucoma will attend a 30-minute session explaining their condition and the importance of lifelong treatment.…

This study is testing whether a laser treatment called DSLT can help control normal tension glaucoma in Asian patients. Researchers want to see if the laser reduces eye pressure and decreases the need for daily eye drop medications. The study will follow 40 participants for 12 mo…

This study is testing whether a 12-week home exercise program can help protect vision in people with glaucoma. Researchers will enroll 150 people, half with glaucoma and half without eye disease, to see if supervised resistance and cycling workouts can improve eye blood flow and …

This study aims to see if a specific combination of eye drops works better than a standard single drop for controlling eye pressure after a laser treatment for glaucoma. It will involve 36 adults with mild to moderate glaucoma who are already using several eye medications. Resear…

This study is testing whether a laser procedure called Direct Selective Laser Trabeculoplasty (DSLT) can reduce daily fluctuations in eye pressure for people with open-angle glaucoma who are already using 1-3 eye drop medications. Researchers will follow 40 participants for 6 mon…

This study aims to find the best patch material for glaucoma drainage surgery. It will compare three types of donor tissue patches to see which one leads to better long-term pressure control, fewer complications, and higher patient comfort. The results will help surgeons choose t…

This study aims to create and test an artificial intelligence (AI) system designed to detect and classify major eye diseases like glaucoma, cataracts, and diabetic retinopathy. Researchers will use about 15,000 existing eye scan images from patients in Costa Rica to train and val…

This study aims to develop and test an artificial intelligence (AI) system to help doctors diagnose five common eye diseases from specialized eye scans called OCT. Researchers will collect scan images and medical information from 2000 patients with conditions like diabetic eye di…

This study aims to find undiagnosed or poorly controlled high blood pressure and glaucoma in adults aged 40 and older living in New York City affordable housing. Researchers will screen over 7,000 people and test if a virtual assistant that sends reminders and health information …

This study is testing whether new AI software helps eye doctors diagnose common eye diseases more accurately and quickly. Ten eye doctors and residents will review eye scan images both with and without the AI's help. The goal is to see if the AI tool improves their diagnostic per…

This small pilot study is testing whether a safe, painless form of brain stimulation can temporarily improve how well adults with severe tunnel vision can get around. Participants will receive a brief session of either real or fake stimulation and then walk a course with obstacle…

This study is testing whether Lumify eye drops can safely reduce eye redness in people with glaucoma who already use similar glaucoma medications. Researchers will measure redness, eye pressure, and eyelid position in 60 participants. The goal is to see if this FDA-approved redne…

This study aims to learn if Rocklatan eye drops improve blood flow to the retina in people with early-stage open-angle glaucoma. Researchers will use special imaging scans to measure blood flow in the eye before and after using the drops for 6 to 12 months. The goal is to underst…

This study aims to understand how glaucoma damages the eye by examining healthy volunteers. Researchers will take pictures of participants' optic nerves before and after they use standard glaucoma eye drops for two weeks. The results will be compared to glaucoma patients to learn…

This study aims to find out if a common type of glaucoma eye drop (prostaglandin analogues) directly protects the eye's vision cells, beyond just lowering pressure. Researchers will look back at the medical records of 1500 adults with glaucoma who have been treated for at least 3…